Location: Princeton, NJ
CIK: 0001388551 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value: $16.64M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| XERS | XERIS BIOPHARMA HOLDINGS INC | 2,015,157 | $6.831M | 41.1% | $2.16 | +48.9% | COM | 98422E103 |
| RZLT | REZOLUTE INC | 1,318,967 | $6.463M | 38.8% | $9.52 | -47.1% | COM NEW | 76200L309 |
| SPY | SPDR S&P 500 ETF TR | 2,823 | $1.654M | 9.9% | $518.47 | — | TR UNIT | 78462F103 |
| BRK/B | BERKSHIRE HATHAWAY INC DEL | 1,133 | $514K | 3.1% | $360.98 | +27.9% | CL B NEW | 084670702 |
| GLD | SPDR GOLD TR | 1,169 | $283K | 1.7% | $242.15 | — | GOLD SHS | 78463V107 |
| — | MIND MEDICINE MINDMED INC | 34,073 | $237K | 1.4% | $8.91 | — | COM NEW | 60255C885 |
| BCAX | BICARA THERAPEUTICS INC | 10,941 | $191K | 1.1% | $25.50 | -18.4% | COM | 055477103 |
| LXEO | LEXEO THERAPEUTICS INC | 17,851 | $117K | 0.7% | $13.31 | -40.8% | COM | 52886X107 |
| KYTX | KYVERNA THERAPEUTICS INC | 22,981 | $85,950 | 0.5% | $23.94 | -80.0% | COM | 501976104 |
| CMPX | COMPASS THERAPEUTICS INC | 43,465 | $63,025 | 0.4% | $3.23 | -48.6% | COM | 20454B104 |
| CRDF | CARDIFF ONCOLOGY INC | 13,287 | $57,665 | 0.3% | $3.13 | 0.0% | COM | 14147L108 |
| IKT | INHIBIKASE THERAPEUTICS INC | 16,393 | $53,277 | 0.3% | $2.49 | 0.0% | COM NEW | 45719W205 |
| — | GLYCOMIMETICS INC | 203,578 | $50,895 | 0.3% | $0.25 | — | COM | 38000Q102 |
| CNTX | CONTEXT THERAPEUTICS INC | 18,403 | $19,324 | 0.1% | $1.72 | +0.4% | COM | 21077P108 |
| — | ADICET BIO INC | 17,488 | $16,823 | 0.1% | $2.35 | — | COM | 007002108 |